CATAPRESAN

Main information

  • Trade name:
  • CATAPRESAN 150 mikrog tablet
  • Dosage:
  • 150 mikrog
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CATAPRESAN 150 mikrog tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Clonidine
  • Product summary:
  • Suitability for use in older adult patients Clonidini hydrochloridum Avoid using in older persons. Sedative. Reduce the dose in renal insufficiency. Significant adverse effects include headache, dizziness, drowsiness, orthostatic hypotension and bradycardia. Take interactions into account, especially with beta blockers.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 5038
  • Authorization date:
  • 06-06-2006
  • Last update:
  • 26-07-2018